Trial Profile
Nebivolol or Metoprolol in Arterial Occlusive Disease: A double-blind, randomised controlled trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Oct 2022
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Metoprolol
- Indications Essential hypertension; Peripheral arterial occlusive disorders
- Focus Pharmacodynamics
- Acronyms NORMA
- Sponsors Berlin Chemie
- 06 Jun 2011 Results published in the Hypertension.
- 06 Jun 2011 Status changed from recruiting to completed.
- 25 Jun 2010 Planned end date (1 Apr 2010) added as reported by ISRCTN: Current Controlled Trials record.